Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

378 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
p53 germline polymorphisms are associated with an increased risk for breast cancer in German women.
Wang-Gohrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB. Wang-Gohrke S, et al. Among authors: kreienberg r. Anticancer Res. 1998 May-Jun;18(3B):2095-9. Anticancer Res. 1998. PMID: 9677474
[Potential tumor preventive effects of hormone preparations].
Kreienberg R, Rossmanith WG. Kreienberg R, et al. Gynakologe. 1993 Apr;26(2):149-56. Gynakologe. 1993. PMID: 8508984 Review. German. No abstract available.
[An unusual case: vaginal foreign body (forceps) as an incidental finding during primary operation for breast cancer].
Möbus VJ, Runnebaum J, Kieback DG, Kreienberg R. Möbus VJ, et al. Among authors: kreienberg r. Geburtshilfe Frauenheilkd. 1995 Apr;55(4):233-4. doi: 10.1055/s-2007-1023308. Geburtshilfe Frauenheilkd. 1995. PMID: 7789715 German.
Value of ultrasound in preoperative local staging in early breast cancer.
Varga D, Wöckel A, Wagner J, Koretz K, Kreienberg R, Sauer G. Varga D, et al. Among authors: kreienberg r. Ultraschall Med. 2011 Aug;32(4):387-92. doi: 10.1055/s-0029-1245243. Epub 2010 Apr 20. Ultraschall Med. 2011. PMID: 20408117
[From alcohol abstinence to total surgery. Preventive strategies in breast carcinoma].
Kreienberg R, Kafka A. Kreienberg R, et al. MMW Fortschr Med. 2003 Jun 12;145(24):32-3. MMW Fortschr Med. 2003. PMID: 12866296 German. No abstract available.
Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin.
Möbus VJ, Moll R, Gerharz CD, Kieback DG, Merk O, Runnebaum IB, Linner S, Dreher L, Grill HJ, Kreienberg R. Möbus VJ, et al. Among authors: kreienberg r. Int J Cancer. 1998 Jul 29;77(3):415-23. doi: 10.1002/(sici)1097-0215(19980729)77:3<415::aid-ijc18>;2-6. Int J Cancer. 1998. PMID: 9663605
Anthracycline and trastuzumab in breast cancer treatment.
Untch M, Himsl I, Kahlert S, Lueck HJ, Eidtmann H, Du Bois A, Meerpohl HG, Thomssen C, Harbeck N, Jackisch C, Kreienberg R, Emons G, Wallwiener D, Wiese W, Schaller G, Kuhn W, Muscholl M, Pauschinger M, Langer B. Untch M, et al. Among authors: kreienberg r. Oncology (Williston Park). 2004 Dec;18(14 Suppl 14):59-64. Oncology (Williston Park). 2004. PMID: 15685838 Clinical Trial.
Bladder carcinoma associated with cyclophosphamide therapy for ovarian cancer occurring with a latency of 20 years.
Volm T, Pfaff P, Gnann R, Kreienberg R. Volm T, et al. Among authors: kreienberg r. Gynecol Oncol. 2001 Jul;82(1):197-9. doi: 10.1006/gyno.2001.6228. Gynecol Oncol. 2001. PMID: 11426986
Predictors of the course of quality of life during therapy in women with primary breast cancer.
Wöckel A, Schwentner L, Krockenberger M, Kreienberg R, Janni W, Wischnewsky M, Thorsten K, Felix F, Riccardo F, Blettner M, Singer S. Wöckel A, et al. Among authors: kreienberg r. Qual Life Res. 2017 Aug;26(8):2201-2208. doi: 10.1007/s11136-017-1570-0. Epub 2017 Apr 6. Qual Life Res. 2017. PMID: 28386772
Do T1a breast cancers profit from adjuvant systemic therapy? A multicenter retrospective cohort study of 325 T1a-patients.
Wolters R, Ebner F, Janni W, Novopashenny I, Wöckel A, Kreienberg R, Wischnewsky M, Schwentner L; Brenda study group. Wolters R, et al. Among authors: kreienberg r. Arch Gynecol Obstet. 2016 Aug;294(2):377-84. doi: 10.1007/s00404-016-4016-y. Epub 2016 Feb 19. Arch Gynecol Obstet. 2016. PMID: 26894302
378 results
Jump to page